Published in Medical Letter on the CDC and FDA, January 20th, 2008
''Leveraging world class R&D, Mindray provides products tailored by both cost and functionality across markets in over 140 countries worldwide,'' said Mr. Xu Hang, Mindray's chairman and co-chief executive officer. "It is our goal to release seven to nine high-quality, competitively-priced products every year, which we achieved in 2007.''
Latest product launches and...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.